• Crohn's disease
  • HER2/neu (ERBB2) Gene Amplification, FISH, Urothelial Carcinoma
  • Immunoglobulin Gene Rearrangement (B-Cell Clonality), Blood
  • Lipase, Body Fluid
  • Post-transplant Rejection Assessment, Kidney, Heart, Lung (Prospera™, AlloSure®, VitaGraft™/GraftAssureDx)
  • MGMT (O-6-methylguanine-DNA methyltransferase) Methylation Detection
  • Campylobacter enteritis (campylobacteriosis)
  • FLG (filaggrin) Gene Mutation Analysis
  • Beta-Glucosidase, Fibroblasts
  • Hereditary hemorrhagic telangiectasia
  • LDS
  • Sign up
  • Log in
  • LDS
  • /Medical Tests
  • /Prosigna Breast Cancer Prognostic Gene Signature
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References
  • All
  • Diseases
  • Overview
  • Clinical Utility
  • Interpretation
  • Reference Ranges
  • Methodology
  • Specimen Collection
  • Additional Testing
  • Turnaround Time
  • CPT
  • LOINC
  • ICD10
  • Additional ICD10
  • References

Prosigna Breast Cancer Prognostic Gene Signature
Medical Test

Reference Ranges
Access to Prosigna Breast Cancer Prognostic Gene Signature is restricted.
Loading...